Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.256 EUR | -1.88% | -9.12% | -8.32% |
Apr. 10 | Transgene: presents vaccine results at AACR | CF |
Mar. 28 | Transgene CFO Steps Down; Successor Assumes Office | MT |
Sales 2023 | 7.9M 8.48M | Sales 2024 * | 39.8M 42.73M | Capitalization | 129M 138M |
---|---|---|---|---|---|
Net income 2023 | -22M -23.62M | Net income 2024 * | -13M -13.96M | EV / Sales 2023 | 17.6 x |
Net Debt 2023 | 1.63M 1.75M | Net Debt 2024 * | 16.4M 17.61M | EV / Sales 2024 * | 3.65 x |
P/E ratio 2023 |
-6.23
x | P/E ratio 2024 * |
-9.14
x | Employees | 143 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 34.45% |
Latest transcript on Transgene
1 day | -1.88% | ||
1 week | -9.12% | ||
Current month | +10.18% | ||
1 month | +13.15% | ||
3 months | -3.83% | ||
6 months | -8.32% | ||
Current year | -8.32% |
Managers | Title | Age | Since |
---|---|---|---|
Alessandro Riva
CEO | Chief Executive Officer | 63 | 22-03-30 |
Lucie Larguier
DFI | Director of Finance/CFO | - | 16-03-31 |
Maud Brandely
CTO | Chief Tech/Sci/R&D Officer | 70 | 16-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 13-06-18 | |
Alain Mérieux
BRD | Director/Board Member | 85 | 90-12-31 |
Director/Board Member | 63 | 04-12-06 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.256 | -1.88% | 6 663 |
24-04-25 | 1.28 | -4.90% | 50,816 |
24-04-24 | 1.346 | +1.82% | 12,204 |
24-04-23 | 1.322 | -0.60% | 15,316 |
24-04-22 | 1.33 | -3.76% | 43,299 |
Real-time Euronext Paris, April 26, 2024 at 04:18 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.32% | 138M | |
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.93% | 22.02B | |
-17.84% | 20.9B | |
-9.35% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |
- Stock Market
- Equities
- TNG Stock